Gestational surrogacy holds the largest market share in the surrogacy market, primarily due to its ability to provide a biological connection between intended parents and the child while minimizing legal and emotional complexities. This dominant position reflects both technological capabilities and evolving legal frameworks. For comprehensive analysis of surrogacy types, refer to the Surrogacy Market report.

Technological Foundation

Gestational surrogacy is characterized by the use of in vitro fertilization (IVF) techniques, where an embryo is created using the egg and sperm of the intended parents or donors and implanted into a gestational carrier. This approach ensures that the surrogate has no genetic relationship to the child, simplifying legal parentage and emotional dynamics. Gestational surrogacy was valued at USD 13.98 billion in 2024, significantly outpacing traditional surrogacy.

Legal Advantages

The absence of genetic connection between surrogate and child simplifies legal parentage establishment in most jurisdictions. Courts and legal systems generally favor gestational surrogacy arrangements, providing clearer pathways for intended parents to establish parental rights.

Success Rates

Advancements in IVF technology have steadily improved success rates for gestational surrogacy. Embryo screening, genetic testing, and enhanced transfer techniques contribute to higher pregnancy rates and reduced risk of complications.

International Appeal

Gestational surrogacy's clear legal framework and technological sophistication make it attractive to international intended parents seeking surrogacy services abroad. Countries with favorable surrogacy laws attract clients from jurisdictions with restrictive regulations.

Market Dominance

Gestational surrogacy benefits from strong legal frameworks and growing societal acceptance, cementing its position as the dominant surrogacy type in the global market.